According to a study published in the journal Frontiers in Pharmacology, researchers, in a double-blind, randomized, placebo-controlled study with 140 patients examined the effects of curcumin (525 mg C3 Complex) plus piperine (2.5 mg Bioperine) on symptoms in patients with COVID-19 as a possible adjuvant therapy for symptomatic COVID-19. The control group received a probiotic (containing lactic acid Bacillus and vitamin B).

The researchers found that the experimental group exhibited faster recovery from many syptoms including fever, cough and shortness of breath.

The anti-inflammatory, antioxidant and other properties of curcumin have been well-researched and the current study underscores opportunities for phytonutrients to play a role in health care optimization and even reduction.